125 related articles for article (PubMed ID: 10951912)
1. [Risperidone and edema: apropos of a case].
Masson M; Elayli R; Verdoux H
Encephale; 2000; 26(3):91-2. PubMed ID: 10951912
[No Abstract] [Full Text] [Related]
2. Self-limited erythema multiforme with risperidone.
Burke GV; Wong DA; Saunders CS; Pierre JM
Gen Hosp Psychiatry; 2009; 31(3):295-6. PubMed ID: 19410111
[No Abstract] [Full Text] [Related]
3. Risperidone-associated steatohepatitis and excessive weight-gain.
Holtmann M; Kopf D; Mayer M; Bechtinger E; Schmidt MH
Pharmacopsychiatry; 2003 Sep; 36(5):206-7. PubMed ID: 14571356
[TBL] [Abstract][Full Text] [Related]
4. Risperidone induced galactorrhea: a case analysis.
Hariharan J; Mohsin J
WMJ; 2002; 101(8):41-3. PubMed ID: 12557612
[TBL] [Abstract][Full Text] [Related]
5. Risperidone-induced priapism.
Makesar D; Thome J
World J Biol Psychiatry; 2007; 8(1):45-7. PubMed ID: 17366350
[TBL] [Abstract][Full Text] [Related]
6. Risperidone in acute and long-term therapy of schizophrenia--a clinical profile.
Pajonk FG
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):15-23. PubMed ID: 14687852
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia.
Baptista T; Martinez M; Lacruz A; Arellano A; Mendoza S; Beaulieu S; Hernández L; Contreras Q; Galeazzi T; Vargas D
Schizophr Res; 2007 Jan; 89(1-3):350-2. PubMed ID: 17029751
[No Abstract] [Full Text] [Related]
8. Dose-dependent acute excessive weight gain and metabolic changes in a drug-naive patient on risperidone are reversible with discontinuation: a case report.
Sahoo S; Mishra B; Akhtar S
Br J Clin Pharmacol; 2007 Nov; 64(5):715-6. PubMed ID: 17509037
[No Abstract] [Full Text] [Related]
9. [Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
Philipp M; Lesch OM; Schmauss M; Dose M; Glaser T
Psychiatr Prax; 2003 May; 30 Suppl 2():S94-6. PubMed ID: 14509050
[TBL] [Abstract][Full Text] [Related]
10. [Urinary retention with risperidone].
Siepmann M; Olbrich H
Psychiatr Prax; 1997 Jul; 24(4):209. PubMed ID: 9340666
[No Abstract] [Full Text] [Related]
11. Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia.
Murashita M; Inoue T; Kusumi I; Nakagawa S; Itoh K; Tanaka T; Izumi T; Hosoda H; Kangawa K; Koyama T
Psychiatry Clin Neurosci; 2007 Feb; 61(1):54-8. PubMed ID: 17239039
[TBL] [Abstract][Full Text] [Related]
12. Risperidone-associated increase in triglyceride levels.
Weinbrenner A; Peus V; Inta D; Englisch S; Zink M
Am J Psychiatry; 2009 Jan; 166(1):113-4. PubMed ID: 19122019
[No Abstract] [Full Text] [Related]
13. Effects of risperidone on lipid profile.
Khalili H; Dashti-Khavidaki S; Okhovatpour H; Ghaeli P
Ann Pharmacother; 2007 May; 41(5):899-900. PubMed ID: 17426072
[No Abstract] [Full Text] [Related]
14. Long-acting risperidone-induced periorbital edema.
Pelizza L
J Clin Psychopharmacol; 2008 Dec; 28(6):709-10. PubMed ID: 19011446
[No Abstract] [Full Text] [Related]
15. Edema associated with addition of risperidone to valproate treatment.
Sanders RD; Lehrer DS
J Clin Psychiatry; 1998 Dec; 59(12):689-90. PubMed ID: 9921707
[No Abstract] [Full Text] [Related]
16. Effect of risperidone on ghrelin and glucose in schizophrenia.
Cohen D
Psychiatry Clin Neurosci; 2007 Oct; 61(5):576. PubMed ID: 17875041
[No Abstract] [Full Text] [Related]
17. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
Dursun S
J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780
[No Abstract] [Full Text] [Related]
18. Risperidone-related weight gain: genetic and nongenetic predictors.
Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
[TBL] [Abstract][Full Text] [Related]
19. New-onset diabetic ketoacidosis in a schizophrenic patient with multiple autoimmune disease during treatment with risperidone.
Sato Y; Yasui-Furukori N; Kaneko S; Moriyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):577-8. PubMed ID: 17919798
[No Abstract] [Full Text] [Related]
20. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
